Inventor · disambiguated record
Brian Pike
Also filed as: PIKE BRIAN · PIKE BRIAN R
7 granted patents·5 pending applications·355 citations·filing 1981–2021
88Inventor score
Files withUNIV FLORIDA3NUFARM AMERICAS INC2ADVANCED ANIMAL DIAGNOSTICS INC1FIN TECH LTD1FURLONG PATRICK J1
Top patents by PatentIndex Score
12 records- 0193US4402402ABarrier seal multiple-compartment packagePIKE BRIAN R·Filed 1981·Granted Sep 6, 1983·147 cites·1 claims
- 0282US7291710B2Detection of spectrin and spectrin proteolytic cleavage products in assessing nerve cell damageUNIV FLORIDA·Filed 2003·Granted Nov 6, 2007·11 cites·29 claims
- 0381US5870884ACompartmented package with multistage permeation barrierFiled 1996·Granted Feb 16, 1999·52 cites·16 claims
- 0481US4854760ADisposable container with applicatorUNIDEC·Filed 1987·Granted Aug 8, 1989·82 cites·13 claims
- 0570US4599008AFingernail polish capsule and plungerFIN TECH LTD·Filed 1985·Granted Jul 8, 1986·36 cites·16 claims
- 0668US4636391AApparatus and method of forming a sterile product packageFURLONG PATRICK J·Filed 1985·Granted Jan 13, 1987·27 cites·15 claims
- 0761US2004241762A1Assessing neuronal damage from blood samplesFiled 2004·Application pending·0 cites
- 0859US2020359627A1Flumioxazin CompositionsNUFARM AMERICAS INC·Filed 2020·Application pending·0 cites
- 0958US2016349272A1Assessing neuronal damage from blood samplesUNIV FLORIDA·Filed 2014·Application pending·0 cites
- 1057US12480941B2Rapid mobile screening and triage for infections and infection severityADVANCED ANIMAL DIAGNOSTICS INC·Filed 2021·Granted Nov 25, 2025·0 cites·20 claims
- 1154US2019191701A1Flumioxazin CompositionsNUFARM AMERICAS INC·Filed 2016·Application pending·0 cites
- 1251US2010184105A1Assessing neuronal damage from blood samplesUNIV FLORIDA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brian Pike files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →